Thursday 21 November 2024

The Pharma Letter Podcast — Episode 4 — The state of biotech investing

Biotechnology
Simon Wentworth
1 September 2021
podcast-episode4-1-

More on this story...

Pharmaceutical
The Pharma Letter Podcast — Episode 5 — Innovation in preleukemia
1 October 2021
Biotechnology
EY report shows Biopharmas shift from M&A to strategic partnerships to boost innovation
10 January 2022
Pharmaceutical
USA’s R&D tax credit bill moves forward
22 January 2024
Pharmaceutical
Life sciences industry optimism for 2024 and 2025 growth
8 May 2024


More ones to watch >


Today's issue

UK reappoints BIA chairman as life sciences investment envoy
Biotechnology
UK reappoints BIA chairman as life sciences investment envoy
21 November 2024
Pharmaceutical
Sage scraps dalzanemdor after disappointing trial results
21 November 2024
Biotechnology
Kura and Kyowa Kirin sign ziftomenib deal
21 November 2024
Biotechnology
HCW Biologics takes aim at CD8+ in deal with WY Biotech
21 November 2024
Pharmaceutical
Leading Tac secures $14 million for IRAK4 degraders
21 November 2024
Biotechnology
Positive top-line data for NewAmsterdam’s obicetrapib and ezetimibe combo
21 November 2024
Biotechnology
Amgen names new president of research
21 November 2024

Company Spotlight

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.




More Features in Biotechnology

UK reappoints BIA chairman as life sciences investment envoy
21 November 2024
Kura and Kyowa Kirin sign ziftomenib deal
21 November 2024
HCW Biologics takes aim at CD8+ in deal with WY Biotech
21 November 2024
Positive top-line data for NewAmsterdam’s obicetrapib and ezetimibe combo
21 November 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze